ICU Medical Inc

ICUI

Company Profile

  • Business description

    ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

  • Contact

    951 Calle Amanecer
    San ClementeCA92673
    USA

    T: +1 949 366-2183

    E: [email protected]

    https://www.icumed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    13,000

Stocks News & Analysis

stocks

Undervalued ASX healthcare provider

Solid demand profile for global leader.
stocks

SpaceX: What investors need to know about its enormous upcoming IPO

Morningstar launches research coverage of SpaceX.
stocks

Fair value lifts for toll road operator as Aussie fuel supply steadies

An Australian fuel shortage is becoming increasingly unlikely, a relief for ASX toll road operator.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,966.0017.100.19%
CAC 408,182.0335.440.44%
DAX 4025,110.49107.450.43%
Dow JONES (US)51,173.9495.060.19%
FTSE 10010,353.9615.010.15%
HKSE26,038.32640.142.52%
NASDAQ27,000.4186.40-0.32%
Nikkei 22566,734.24200.09-0.30%
NZX 50 Index13,170.7173.84-0.56%
S&P 5007,591.288.68-0.11%
S&P/ASX 2008,724.4017.700.20%
SSE Composite Index4,075.1017.360.43%

Market Movers